General Information
Revision date
2022-05-12
Product name
INCRUSE ELLIPTA
Product Synonyms
INCRUSE * ROLUFTA * VANISTO * UMECLIDINIUM BROMIDE, FORMULATED PRODUCT
CAS No.
869113-09-7
1.2.2. Uses advised against
No other uses are advised
supplier name
GlaxoSmithKline US
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, inhalation Category 4
Environmental hazards
Hazardous to the aquatic environment, acute Category 3 Hazardous to the aquatic environment, Category 3
Signal word
Warning
Hazard statements
Harmful if inhaled. Harmful to aquatic life. Harmful to aquatic life with long lasting effects.
Prevention
Avoid breathing dust. Use only outdoors or in a well-ventilated area. Avoid release to the environment.
Response
IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTRE/doctor if you feel unwell.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
1 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99.5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 99.5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 99.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
